株式会社D&Mカンパニー Logo

株式会社D&Mカンパニー

Optimizing healthcare & welfare businesses via finance, consulting, and HR solutions.

189A | T

Overview

Corporate Details

ISIN(s):
JP3548490006
LEI:
Country:
Japan
Address:
大阪市北区梅田二丁目5番25号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

D&M COMPANY CO.,LTD is a specialized provider of comprehensive business support services for the medical, nursing care, and welfare industries. The company offers integrated, one-stop solutions structured around three core pillars: Finance & Investment (F&I), Consulting & Business Renovation (C&Br), and Human Resources & Outsourcing (HR&OS). The F&I division provides financial solutions such as medical fee receivables factoring and leasing. The C&Br division offers management consulting, including organizational reform, profit improvement support, and M&A advisory. The HR&OS division delivers staffing services like personnel placement, temporary staffing, and outsourcing. By holistically addressing key client challenges in finance, management, and human resources, D&M aims to achieve overall business optimization for healthcare and welfare service providers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 07:31
Registration Form
有価証券届出書(組込方式)
Japanese 330.4 KB
2025-08-25 06:04
Registration Form
有価証券報告書-第10期(2024/06/01-2025/05/31)
Japanese 1.3 MB
2025-08-25 06:04
Registration Form
確認書
Japanese 9.2 KB
2025-01-14 05:43
Report Publication Announcement
確認書
Japanese 9.3 KB
2025-01-14 05:41
Interim Report
半期報告書-第10期(2024/06/01-2025/05/31)
Japanese 179.0 KB
2024-08-27 03:02
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-08-26 08:01
Registration Form
確認書
Japanese 8.8 KB
2024-08-26 08:00
Annual Report
有価証券報告書-第9期(2023/06/01-2024/05/31)
Japanese 1.3 MB
2024-06-03 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2024-05-24 02:30
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2024-05-08 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 3.0 MB

Automate Your Workflow. Get a real-time feed of all 株式会社D&Mカンパニー filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社D&Mカンパニー

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社D&Mカンパニー via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

QUINSTREET, INC Logo
AI-driven marketplaces connecting consumers to brands in finance & home services on a pay-per-result basis.
United States of America
QNST
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978

Talk to a Data Expert

Have a question? We'll get back to you promptly.